Browsing by Subject

A plain language summary of what clinical studies can tell us about the safety of evobrutinib – a potential treatment for multiple sclerosis

wallace, daniel; Genovese, Mark C; Tomic, Davorka Lucia; Parsons-Rich, Dana; Bolay, Claire Le; Montalban, Xavier (Future Medicine, 2023-08)

Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis

Rotstein, Dalia; Solomon, Jacqueline; Sormani, Maria Pia; Montalban Gairín, Xavier; Ye, Xiang Y.; Dababneh, Dina (Wolters Kluwer Health, 2022-11)

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Simpson-Yap, Steve; De Brouwer, Edward; Kalincik, Tomas; Rijke, Nick; Hillert, Jan A.; Walton, Clare; Zabalza de Torres, Ana; Arrambide García, Georgina (Wolters Kluwer Health, 2021-11-09)

Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data

Jones, Joanne; Vermersch, Patrick; Bass, Ann D; Boster, Aaron; Montalban Gairín, Xavier; Coles, Alasdair; Traboulsee, Anthony (SAGE Publications, 2022-04-01)

Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method

Gold, Ralf; Barnett, Michael; Chan, Andrew; Feng, Huiyu; Fujihara, Kazuo; Giovannoni, Gavin; Montalban, Xavier; Tintore, Mar (SAGE Publications, 2023-07-14)

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

Meca-Lallana, Jose Eustasio; Fernández-Prada, María; Garcia Vázquez, Elisa; Moreno Guillén, S.; Otero Romero, Susana; Rus-Hidalgo, Macarena; Montalban Gairín, Xavier (Elsevier, 2022-10)

Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis

Filippi, Massimo; Danesi, Romano; Derfuss, Tobias; Duddy, Martin; Gallo, Paolo; Tintore Subirana, Mar; Gold, Ralf (Springer, 2022-03)

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS

DeLuca, John; Schippling, Sven; Montalban Gairín, Xavier; Kappos, Ludwig; Cree, Bruce; Comi, Giancarlo (Elsevier, 2021-02)

Expert-Agreed Practical Recommendations on the Use of Cladribine

García Domínguez, José M.; López Ruiz, Rocío; Martín-Martínez, Jesús; Ares-Luque, Adrian; Hernández Pérez, Miguel A.; Sastre Garriga, Jaume; Meca-Lallana, Virginia (Springer, 2022-12)

Immunomodulatory Effects Associated with Cladribine Treatment

Fissolo, Nicolás Miguel; Calvo Barreiro, Laura; Eixarch Ahufinger, Herena; Boschert, Ursula; Espejo Ruiz, Carmen; Montalban Gairín, Xavier; Comabella Lopez, Manuel (MDPI, 2021-12)

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial

Cree, Bruce; Selmaj, Krzysztof W.; Steinman, Lawrence; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Montalban Gairín, Xavier (SAGE Publications, 2022-10)

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Selmaj, Krzysztof W.; Cohen, Jeffrey A; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Steinman, Lawrence; Montalban Gairín, Xavier (Elsevier, 2021-06)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

Camacho‑Toledano, Celia; Machín Díaz, Isabel; Calahorra Melero, L.; Cabañas‑Cotillas, María; Otaegui, David; Midaglia Fernandez, Luciana; Castillo-Trivino, Tamara; Comabella Lopez, Manuel (BMC, 2022-11-19)

Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis

Zanga, Gisela Mariel; Drzewiscki, Estefania; Tagliani, Paula; Smietniansky, Maximiliano; Esnaola Rojas, Maria M.; Caruso, Diego (SAGE Publications, 2021-10-05)

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español

Otero Romero, Susana; Rodríguez-García, J.; Vilella, A.; Ara Callizo, José Ramón; Brieva Ruiz, Luis; Calles, C.; Tintore Subirana, Mar (Elsevier, 2021-01)

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab

Walo-Delgado, Paulette Esperanza; Monreal, Enric; Medina, Silvia; Quintana, Ester; Fernández-Velasco, José Ignacio; Montalban Gairín, Xavier; Midaglia Fernandez, Luciana; Sainz de la Maza, Susana; Comabella Lopez, Manuel (Frontiers Media, 2021-10)

Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study

Coles, Alasdair; Traboulsee, Anthony; Singer, Barry A; Pozzilli, Carlo; Oreja-Guevara, C.; Achiron, Anat; Montalban, Xavier (SAGE Publications, 2023-09-21)

Scientia. Dipòsit d'Informació Digital del Departament de Salut